Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShares OutstandingShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Haemonetics (HAE) Retained Earnings (2016 - 2025)

Haemonetics (HAE) has 16 years of Retained Earnings data on record, last reported at -$34.6 million in Q4 2025.

  • For Q4 2025, Retained Earnings rose 37.64% year-over-year to -$34.6 million; the TTM value through Dec 2025 reached -$34.6 million, up 37.64%, while the annual FY2025 figure was $352.2 million, 2.3% down from the prior year.
  • Retained Earnings reached -$34.6 million in Q4 2025 per HAE's latest filing, down from $336.3 million in the prior quarter.
  • Across five years, Retained Earnings topped out at $386.6 million in Q2 2024 and bottomed at -$55.5 million in Q4 2024.
  • Average Retained Earnings over 5 years is $138.7 million, with a median of $173.6 million recorded in 2021.
  • Peak YoY movement for Retained Earnings: tumbled 137.63% in 2021, then skyrocketed 1409.85% in 2024.
  • A 5-year view of Retained Earnings shows it stood at -$29.5 million in 2021, then decreased by 21.2% to -$35.8 million in 2022, then skyrocketed by 1050.02% to $340.1 million in 2023, then tumbled by 116.32% to -$55.5 million in 2024, then soared by 37.64% to -$34.6 million in 2025.
  • Per Business Quant database, its latest 3 readings for Retained Earnings were -$34.6 million in Q4 2025, $336.3 million in Q3 2025, and -$36.2 million in Q2 2025.